Innate Pharma's Expanded IO AstraZeneca Deal Jump-Starts US Ambitions

 
• By John Davis
  
Jump start
Expanded collaboration electrifies Innate's US commercial ambitions • Source: Shutterstock.

More from Immuno-oncology

More from Anticancer